Overcoming subtype-specific immune resistance in small cell lung cancer through RNA-based immunotherapy

Small cell lung cancer (SCLC) comprises neuroendocrine (NE) and non-neuroendocrine (non-NE) subtypes with distinct immune landscapes and responses to therapy. Here, we established murine experimental metastases models to investigate RNA vaccination across SCLC subtypes. These exhibited distinct organotrophic properties and differ in both the magnitude and kinetics of interferon-induced MHC-I upregulation. Vaccination controlled non-NE tumors but provided limited survival benefit against NE tumors established in the lung or liver. Single-nucleus RNA sequencing and chromatin accessibility profiling revealed inflammation-associated programs following vaccination shared between organs. To overcome the limited survival benefit of vaccination in NE SCLC, we combined RNA vaccination with liver-targeted RNA-encoded cytokines. This combination markedly prolonged survival of NE tumor-bearing mice and enhanced inflammatory immune activity within the tumor microenvironment. Together, these findings identify vaccination-associated inflammatory programs of potential clinical relevance and warrant further investigation of cytokine combination therapy as strategy to improve immunotherapy in NE SCLC.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.17.767319
Primary Topic
Lung Cancer Research Studies
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Overcoming subtype-specific immune resistance in small cell lung cancer through RNA-based immunotherapy

Julia Zimmermann, Barbara Schrörs, Krutika Khinvasara, Ioanna Tsoukala et al.
4 links
bioRxiv (Cold Spring Harbor Laboratory)
Lung Cancer Research Studies
preprint

Overcoming subtype-specific immune resistance in small cell lung cancer through RNA-based immunotherapy

Julia Zimmermann, Barbara Schrörs, Krutika Khinvasara, Ioanna Tsoukala, Maik Schork, Franziska Lang, Filippo Beleggia, Tommaso Torcellan, Ayline Kübler, Özlem Akilli‐Öztürk, LAURA D. KOLB, Jennifer V. Gerbracht, Uğur Şahin, Elif Diken, Mustafa Diken, M Suchan, Ines Beulshausen, Aniello Federico, Kevin Berg, H. Christian Reinhardt, Kimberly Wohde
preprint en

Abstract

Small cell lung cancer (SCLC) comprises neuroendocrine (NE) and non-neuroendocrine (non-NE) subtypes with distinct immune landscapes and responses to therapy. Here, we established murine experimental metastases models to investigate RNA vaccination across SCLC subtypes. These exhibited distinct organotrophic properties and differ in both the magnitude and kinetics of interferon-induced MHC-I upregulation. Vaccination controlled non-NE tumors but provided limited survival benefit against NE tumors established in the lung or liver. Single-nucleus RNA sequencing and chromatin accessibility profiling revealed inflammation-associated programs following vaccination shared between organs. To overcome the limited survival benefit of vaccination in NE SCLC, we combined RNA vaccination with liver-targeted RNA-encoded cytokines. This combination markedly prolonged survival of NE tumor-bearing mice and enhanced inflammatory immune activity within the tumor microenvironment. Together, these findings identify vaccination-associated inflammatory programs of potential clinical relevance and warrant further investigation of cytokine combination therapy as strategy to improve immunotherapy in NE SCLC.

bioRxiv (Cold Spring Harbor Laboratory)
University of Cologne (DE), Johannes Gutenberg University Mainz (DE), University Medical Center of the Johannes Gutenberg University Mainz (DE), Essen University Hospital (DE), Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz (DE), University Hospital Cologne (DE)
Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe
Good health and well-being
Lung Cancer Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon